Skip to main content

Table 2 Whole Genome Sequencing predicted antibiotic susceptibility for 33 non-duplicate GBS isolates (See Supplemental Table 1 for MIC prediction values)

From: Whole genome sequence based capsular typing and antimicrobial resistance prediction of Group B streptococcal isolates from colonized pregnant women in Nigeria

Antibiotic Targeted genes Susceptible (%) Non-Susceptible *(%)
Ampicillin pbp2X 33 (100) -
Ceftriaxone pbp2X 33 (100) -
Chloramphenicol cat 25 (75.6) 8 (24.2)
Clindamycin erm 25 (75.6) 8 (24.2)
Ceftaroline pbp2X 33 (100) -
Erythromycin erm or mef 23 (69.7) 10 (30.3)
Levofloxacin parC, gyrA 24 (72.7) 9 (27.3)
Meropenem pbp2X 33 (100) -
Linezolid 23 S rRNA 33 (100) -
Penicillin pbp2X 33 (100) -
Synercid** erm + lsa 33 (100) -
Cefotaxime pbp2X 33 (100) -
Tetracycline tet - 33 (100)
Vancomycin van 33 (100) -
  1. ** Quinupristin/Dalfopristin
  2. *Non-susceptibility includes both intermediate and resistant prediction